Glaxosmithkline (GSK)

 

GSK Share PerformanceMore

52 week high1,745.5 11/10/16
52 week low1,446.5 06/12/16
52 week change -190.5 (-11.34%)
4 week volume162,219,703 23/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Down 50% since March but still a 'buy'

This FTSE 250 pharma has seen half its value wiped off in just five months. But Graeme Evans finds one positive analyst ...

Director/PDMR Shareholding

RNS Number: 7095N GlaxoSmithKline PLC 10 August 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participa...

Director/PDMR Shareholding

RNS Number: 6530N GlaxoSmithKline PLC 10 August 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mrs V A Whyte b) Position/status SVP & Company Secretary c) Initial notification/ amendment Initial Notification 2. Details of the issuer, emission allowance market parti...

Broker Forecast - Berenberg issues a broker note on GlaxoSmithKline PLC

Berenberg today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1835p...

Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLC

Deutsche Bank today reaffirms its hold investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to...

Base prospectus re ?15bn EMTN programme

RNS Number: 1341N GlaxoSmithKline PLC 04 August 2017 Publication of Base Prospectus The following base prospectus dated 3 August 2017 has been approved by the UK Listing Authority and is available for viewing: GlaxoSmithKline plc, GlaxoSmithKline Capital plc and GSK Capital K.K. 15,000,000,000 Euro Medium Term Note Programme Copies of the base pro...

Total Voting Rights

RNS Number: 7419M GlaxoSmithKline PLC 01 August 2017 GlaxoSmithKline plc Total Voting Rights and Capital In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following: The Company's issued share capital as at 31 July 2017 consisted of 5,371,684,285 ordinary shares of 25 pence each...

Share of the Week: This healthcare small-cap could treble

This FTSE 250 drug-maker went in the opposite direction to AstraZeneca this week and now one analyst is tipping it up to ...

Fundamental DataMore

P/E ratio79.255
EPS18.8
Dividend yield5.369 %

Latest discussion posts More

  • Re: Deutsche Bank: reinvestment means GSK fa...

    ""However, reinvigorating pharma R&D will not be a quick fix""" Makes you wonder why there has been no invigoration of the pharma business over the last years then? Getting ...
    9-Aug-2017
    gamesinvestor
  • Deutsche Bank: reinvestment means GSK faces margins fight

    Earnings per share growth at GlaxoSmithKline (GSK) will be limited over the next three years, predicts Deutsche Bank, as the pharma giant invests to improve its research and ...
    8-Aug-2017
    IOMINVESTCOM
  • One for Woody

    Shire announced their Q2 results just now and they were pretty ...
    3-Aug-2017
    gamesinvestor

Users' HoldingsMore

Users who hold Glaxosmithkline also hold..
BP34%
VODAFONE GRP.34%
LLOYDS GRP.32%
NATIONAL GRID32%
RDS 'B'31%

Codes & Symbols

ISINGB0009252882
SymbolsGSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK